AR036276A1 - Uso de un compuesto 15-ceto-prostaglandina para el tratamiento de hipertension ocular y glaucoma - Google Patents
Uso de un compuesto 15-ceto-prostaglandina para el tratamiento de hipertension ocular y glaucomaInfo
- Publication number
- AR036276A1 AR036276A1 ARP020103150A ARP020103150A AR036276A1 AR 036276 A1 AR036276 A1 AR 036276A1 AR P020103150 A ARP020103150 A AR P020103150A AR P020103150 A ARP020103150 A AR P020103150A AR 036276 A1 AR036276 A1 AR 036276A1
- Authority
- AR
- Argentina
- Prior art keywords
- glaucoma
- compound
- prostaglandine
- ceto
- treatment
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/557—Eicosanoids, e.g. leukotrienes or prostaglandins
- A61K31/5575—Eicosanoids, e.g. leukotrienes or prostaglandins having a cyclopentane, e.g. prostaglandin E2, prostaglandin F2-alpha
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/06—Antiglaucoma agents or miotics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Ophthalmology & Optometry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Se provee el uso de un compuesto 15-ceto-prostaglandina que tiene una estructura cíclica al final de la cadena omega para preparar una composición oftálmica para tratar hipertensión arterial y glaucoma de un mamífero, donde dicha composición debe administrarse en los ojos del sujeto una vez por día. De acuerdo con la presente, la administración única de la composición reduce efectivamente la PIO del sujeto durante todo el día.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US31411001P | 2001-08-23 | 2001-08-23 |
Publications (1)
Publication Number | Publication Date |
---|---|
AR036276A1 true AR036276A1 (es) | 2004-08-25 |
Family
ID=23218598
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ARP020103150A AR036276A1 (es) | 2001-08-23 | 2002-08-22 | Uso de un compuesto 15-ceto-prostaglandina para el tratamiento de hipertension ocular y glaucoma |
Country Status (12)
Country | Link |
---|---|
US (1) | US20030060511A1 (es) |
EP (1) | EP1420793A1 (es) |
JP (1) | JP2004521960A (es) |
KR (1) | KR20040029012A (es) |
CN (1) | CN1575178A (es) |
AR (1) | AR036276A1 (es) |
BR (1) | BR0205932A (es) |
CA (1) | CA2458230A1 (es) |
MX (1) | MXPA04001604A (es) |
NO (1) | NO20031779L (es) |
WO (1) | WO2003018025A1 (es) |
ZA (1) | ZA200302911B (es) |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2005519978A (ja) * | 2002-03-28 | 2005-07-07 | スキャンポ・アーゲー | 高眼圧症および緑内障の処置方法 |
US20040225014A1 (en) * | 2003-02-14 | 2004-11-11 | Sucampo Ag | Method for treating ocular hypertension and glaucoma |
US10206813B2 (en) | 2009-05-18 | 2019-02-19 | Dose Medical Corporation | Implants with controlled drug delivery features and methods of using same |
KR20140035363A (ko) | 2011-04-07 | 2014-03-21 | 수캄포 아게 | 안정피로 치료 방법 |
Family Cites Families (16)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3932389A (en) * | 1974-12-11 | 1976-01-13 | Pfizer Inc. | 2-Descarboxy-2-(tetrazol-5-yl)-11-desoxy-15-substituted-.omega.-pentanorprostaglandins |
US5212200A (en) * | 1987-09-18 | 1993-05-18 | R-Tech Ueno, Ltd. | Ocular hypotensive agents |
US5321128A (en) * | 1988-09-06 | 1994-06-14 | Kabi Pharmacia Ab | Prostaglandin derivatives for the treatment of glaucoma or ocular hypertension |
US6187813B1 (en) * | 1990-04-10 | 2001-02-13 | Pharmacia & Upjohn Aktiebolag | Prostaglandin derivatives for the treatment of glaucoma or ocular hypertension |
WO1990002553A1 (en) * | 1988-09-06 | 1990-03-22 | Pharmacia Ab | Prostaglandin derivatives for the treatment of glaucoma or ocular hypertension |
US5296504A (en) * | 1988-09-06 | 1994-03-22 | Kabi Pharmacia | Prostaglandin derivatives for the treatment of glaucoma or ocular hypertension |
US5194429A (en) * | 1988-10-01 | 1993-03-16 | K.K. Ueno Seiyaku Oyo Kenkyujo | Ocular hypotensive agents |
EP0366279B1 (en) * | 1988-10-01 | 1994-09-21 | R-Tech Ueno Ltd. | Ocular hypotensive agents |
CA2039420C (en) * | 1990-04-04 | 1996-12-10 | Ryuji Ueno | Treatment of cataract with 15-keto-prostaglandin compounds |
DK0458588T3 (da) * | 1990-05-22 | 1995-03-13 | R Tech Ueno Ltd | Behandling af okulær hypertension med en synergistisk kombination til okulær administration |
CA2046069C (en) * | 1990-07-10 | 2002-04-09 | Ryuji Ueno | Treatment of inflammatory diseases with 15-keto-prostaglandin compounds |
AU687906B2 (en) * | 1993-12-15 | 1998-03-05 | Alcon Laboratories, Inc. | Use of certain prostaglandin analogues to treat glaucoma and ocular hypertension |
TW420611B (en) * | 1995-03-10 | 2001-02-01 | R Tech Ueno Ltd | Pharmaceutical composition containing prostanoic acid compounds for the treatment of optic nerve disorder |
AU7680096A (en) * | 1995-12-22 | 1997-07-17 | Alcon Laboratories, Inc. | Combinations of dp and fp type prostaglandins for lowering iop |
US6458836B1 (en) * | 2000-03-16 | 2002-10-01 | Sucampo, A.G. | Treatment of ocular hypertension and glaucoma |
US20020035148A1 (en) * | 2000-07-20 | 2002-03-21 | Ryuji Ueno | Treatment of ocular hypertension |
-
2002
- 2002-08-22 WO PCT/JP2002/008446 patent/WO2003018025A1/en not_active Application Discontinuation
- 2002-08-22 AR ARP020103150A patent/AR036276A1/es unknown
- 2002-08-22 US US10/224,923 patent/US20030060511A1/en not_active Abandoned
- 2002-08-22 CN CNA028209214A patent/CN1575178A/zh active Pending
- 2002-08-22 BR BR0205932-0A patent/BR0205932A/pt not_active Application Discontinuation
- 2002-08-22 JP JP2003522543A patent/JP2004521960A/ja not_active Withdrawn
- 2002-08-22 MX MXPA04001604A patent/MXPA04001604A/es unknown
- 2002-08-22 CA CA002458230A patent/CA2458230A1/en not_active Abandoned
- 2002-08-22 EP EP02760691A patent/EP1420793A1/en not_active Withdrawn
- 2002-08-22 KR KR10-2004-7002670A patent/KR20040029012A/ko not_active Application Discontinuation
-
2003
- 2003-04-14 ZA ZA200302911A patent/ZA200302911B/xx unknown
- 2003-04-22 NO NO20031779A patent/NO20031779L/no not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
NO20031779D0 (no) | 2003-04-22 |
ZA200302911B (en) | 2003-10-14 |
WO2003018025A1 (en) | 2003-03-06 |
CN1575178A (zh) | 2005-02-02 |
JP2004521960A (ja) | 2004-07-22 |
EP1420793A1 (en) | 2004-05-26 |
BR0205932A (pt) | 2004-02-17 |
KR20040029012A (ko) | 2004-04-03 |
NO20031779L (no) | 2003-04-22 |
CA2458230A1 (en) | 2003-03-06 |
MXPA04001604A (es) | 2004-07-08 |
US20030060511A1 (en) | 2003-03-27 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AR039130A2 (es) | Metodo de administracion de un agente farmaceuticamente activo a un ojo humano | |
CO6351718A2 (es) | Suministro de liberacion sostenida de agentes activos para tratar glaucoma e hipertension ocular | |
AR039131A2 (es) | Metodo para administrar un agente farmaceuticamente activo a un tejido a ser tratado en un cuerpo y metodo para administrar un agente farmaceuticamente activo a un ojo | |
DK1385452T3 (da) | Anordning til tilförsel af et ophthalmisk medikament | |
UY28709A1 (es) | Derivados de prostaglandinas | |
BR0302584A (pt) | Combinação de brimonidina e timolol para uso oftálmico tópico | |
ES2189002T3 (es) | Procedimiento in vitro y utilizacion de composiciones farmaceuticas para el tratamiento de celulas ciliares del oido interno. | |
PT671910E (pt) | Utilizacao de derivados de adamantano no fabrico de um medicamento para o tratamento do glaucoma | |
BRPI0509220A (pt) | método, formulação oftálmica e kit para para o tratamento de olho ressecado moderno a grave; método para o tratamento de olho ressecado crÈnico; e métodos para reduzir a vermelhidão e a produção de citocinas inflamatórias por células no epitélio | |
DE602004030931D1 (es) | ||
ATE420624T1 (de) | Pharmazeutische zusammensetzungen zurbehandlung von augenerkrankungen | |
AR035541A1 (es) | Un metodo de tratamiento para pacientes que sufren de glaucoma severo o necesitan una reduccion de la presion intraocular (pio) y el uso de una combinacion de agentes reductores de la pio | |
Ferris | Results of 20 years of research on the treatment of diabetic retinopathy | |
AR009028A1 (es) | Composiciones farmaceuticas, un procedimiento para preparar dichas composiciones y utilizacion de dichas composiciones en el tratamiento deenfermedades oftalmicas y metodos para tratar dichas enfermedades | |
AR031288A1 (es) | Metodos y composiciones para el tratamiento de enfermedades oftalmicas | |
AR036276A1 (es) | Uso de un compuesto 15-ceto-prostaglandina para el tratamiento de hipertension ocular y glaucoma | |
BR0214196A (pt) | Método e composição para reduzir a atividade de inibir o crescimento de uma célula cancerosa, para tratar de paciente com câncer | |
DK1621207T3 (da) | Mixture of defibrotide and G-CSF, and its use for activating haematopoietic progenitors | |
AR033207A1 (es) | Metodo de tratamiento de desordenes inflamatorios oculares y de desordenes relacionados con angiogenesis del segmento posterior del ojo usando un derivado amida de flurbiprofen o ketorolac | |
BR0209601A (pt) | Método para o tratamento da hipertensão ocular e do glaucoma | |
IT9086204A1 (it) | Metodo per la cura dell'impotenza erettiva maschile | |
MXPA04000980A (es) | Tratamiento de hipertension ocular y glaucoma. | |
KR910019622A (ko) | 안과용 상승적 병용으로 안고혈압의 치료 | |
IT1305294B1 (it) | Uso del nerve growth factor nella terapia di patologie a carico deitessuti intraoculari. | |
AR045766A1 (es) | Procedimiento mejorado de tratamiento de trastornos del crecimiento |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FB | Suspension of granting procedure |